Groesbeck Parham to Mass Screening
This is a "connection" page, showing publications Groesbeck Parham has written about Mass Screening.
Connection Strength
4.878
-
Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study. Lancet Glob Health. 2026 Jan; 14(1):e49-e60.
Score: 0.872
-
The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology. J Am Coll Surg. 2021 04; 232(4):636-640.
Score: 0.615
-
Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
Score: 0.538
-
Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
Score: 0.451
-
Minimizing verification bias in cervical cancer screening of HIV-infected women. Int J Gynaecol Obstet. 2015 Mar; 128(3):269-70.
Score: 0.402
-
Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet. 2014 Jul; 126(1):88-89.
Score: 0.384
-
Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010 Jun; 17(2 Suppl):47-50.
Score: 0.296
-
HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Jul 16; 361(3):305; author reply 306.
Score: 0.279
-
Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
Score: 0.195
-
Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
Score: 0.104
-
Can you screen for ovarian cancer? J Natl Med Assoc. 1995 Feb; 87(2):109-12.
Score: 0.102
-
Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
Score: 0.100
-
Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
Score: 0.084
-
Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS. 2009 Mar 27; 23(6):N1-5.
Score: 0.068
-
Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008 Aug; 86(8):D-E.
Score: 0.065
-
Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008 Sep; 110(3):402-7.
Score: 0.065
-
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
Score: 0.057
-
Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006; 16(2 Suppl 3):S3-63-6.
Score: 0.055
-
A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
Score: 0.045
-
Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol. 2000 Mar; 95(3):340-4.
Score: 0.036
-
Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
Score: 0.033
-
The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
Score: 0.026
-
Screening for endometrial cancer. J Natl Med Assoc. 1994 Aug; 86(8):577-9.
Score: 0.006